The benefits of combined hormonal contraceptives (CHCs), even those considered third and fourth generation, continue to outweigh the small risk for venous thromboembolism (VTE), the European Medicines ...
Physical Examination in Medical Oncology Guiding the Development of a Protocol for Teleoncology Care in a Public Health Care Oncology Service The prediction ML models showed good performance to ...
About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results